TY - JOUR
T1 - Towards More Shared Decision Making in Dermatology: Develop-ment of Evidence-based Decision Cards for Psoriasis and Atopic Eczema Treatments
AU - Vermeulen, Francisca M.
AU - van der Kraaij, Gayle E.
AU - Tupker, Ronald A.
AU - Bijlsma, Anne
AU - Blaauwbroek, Hans
AU - Das, Francine
AU - Geltink, Tessa
AU - van der Kraan, Josine S.
AU - Kranenburg, Renske
AU - van der Veen, Dirk J.
AU - Venhorst, Kristie
AU - Spuls, Phyllis I.
PY - 2020/12/1
Y1 - 2020/12/1
N2 - In shared decision making (SDM) patients and physi-cians make treatment decisions together based on the best available evidence and the values and preferences of patients. SDM is very suitable for use in dermatological practice, but is infrequently applied by dermatologists. To support the application of SDM in dermatology we developed Decision Cards: 1-page overviews of possible treatment options, for use during a patient-physician consultation. Decision Cards provide answers to patients' most frequently asked questions, based on (inter)national guidelines, Summary of Product Characteristics, relevant literature, and clinical expertise. Three evidence-based Decision Cards were developed: 1 for biologicals or apremilast in psoriasis, and 2 for atopic eczema (1 for topical, photo- or systemic therapy, and 1 for systemic therapy only). More cards for psoriasis are currently in development. Patients, dermatologists and researchers collaborated in the development of the Decision Cards. This paper shares the framework used for the development of the Decision Cards, in order to support others in the development process.
AB - In shared decision making (SDM) patients and physi-cians make treatment decisions together based on the best available evidence and the values and preferences of patients. SDM is very suitable for use in dermatological practice, but is infrequently applied by dermatologists. To support the application of SDM in dermatology we developed Decision Cards: 1-page overviews of possible treatment options, for use during a patient-physician consultation. Decision Cards provide answers to patients' most frequently asked questions, based on (inter)national guidelines, Summary of Product Characteristics, relevant literature, and clinical expertise. Three evidence-based Decision Cards were developed: 1 for biologicals or apremilast in psoriasis, and 2 for atopic eczema (1 for topical, photo- or systemic therapy, and 1 for systemic therapy only). More cards for psoriasis are currently in development. Patients, dermatologists and researchers collaborated in the development of the Decision Cards. This paper shares the framework used for the development of the Decision Cards, in order to support others in the development process.
KW - Atopic eczema
KW - Decision card
KW - Encounter decision aids
KW - Psoriasis
KW - Shared decision making
UR - http://www.scopus.com/inward/record.url?scp=85097112914&partnerID=8YFLogxK
U2 - https://doi.org/10.2340/00015555-3614
DO - https://doi.org/10.2340/00015555-3614
M3 - Article
C2 - 32812056
SN - 0001-5555
VL - 100
SP - 1
EP - 8
JO - Acta Dermato-Venereologica
JF - Acta Dermato-Venereologica
IS - 19
M1 - adv00337
ER -